Endovascular Reconstruction for Total Aorto-Iliac Occlusion

Gabriele Piffaretti1, Aaron Thomas Fargion2, Walter Dorigo2

  • 1Vascular Surgery, Department of Medicine and Surgery, University of Insubria School of Medicine, ASST Settelaghi Universitary Teaching Hospital, Varese, Italy.

Insights

Endovascular treatment for total aortic occlusion showed high technical success and promising 3-year patency rates. These outcomes were achieved using percutaneous and hybrid techniques, unaffected by occlusion extent or method.

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Aorto-Iliac Disease

Background:

  • Aorto-iliac occlusive disease, particularly total occlusion, presents complex challenges for treatment.
  • Endovascular techniques offer a less invasive approach compared to open surgery.

Purpose of the Study:

  • To analyze the outcomes of endovascular treatment for total occlusion of the infrarenal aorta and aorto-iliac bifurcation.
  • To assess technical success, mortality, patency rates, and need for conversion to open surgery.

Main Methods:

  • A multicenter, retrospective, observational cohort study included 54 patients with total infrarenal aorta and aorto-iliac bifurcation occlusion.
  • Patients underwent percutaneous or hybrid endovascular revascularization, with techniques like kissing-stent-graft, CERAB, or unibody endograft.
  • Outcomes included early technical success and mortality, and late primary/secondary patency and freedom from conversion to open surgery.

Main Results:

  • Technical success was achieved in 98.1% of patients, with no intraoperative or perioperative ruptures or in-hospital deaths.
  • Estimated primary patency rates at 3 years were 85%, with secondary patency at 95.5%.
  • No patients required conversion to open surgery during follow-up, and patency was not significantly affected by occlusion extent or revascularization type.

Conclusions:

  • Endovascular reconstruction is a successful strategy for total infrarenal aorta and aorto-iliac bifurcation occlusion.
  • Percutaneous and hybrid techniques yield promising 3-year patency rates, offering a viable alternative to open surgery.
Abstract